Latest Blogs

Feb 23, 2021
In their roles as patient advocates, Ms. Janine Guglielmino and Dr. Sue Friedman have observed growing patient confusion about breast cancer subtypes and the difference between acquired and inherited gene mutations.
Feb 18, 2021
This is a time of significant and multi-layered anxiety, especially for our patients living with and beyond cancer. 
Feb 11, 2021
"My motto is to stand up for all the people who face casual racism, sexism, and injustice, and my aim is to protect international trainees in medicine when it is my turn to be a mentor," Dr. Viju Chandrasekhar affirms as she shares a personal experience with bias based on her accent.
Feb 11, 2021
Our oncology training is shaped by those who devote their time to helping us turn our weaknesses into strengths, and all of us have a role to play as teachers.
Subscribe to this column

Clifford A. Hudis, MD, FACP, FASCO

Clifford A. Hudis, MD, FACP, FASCO, is the CEO of ASCO, executive vice chair of Conquer Cancer, the ASCO Foundation, and chair of CancerLinQ. Prior to these roles, he served as chief of the Breast Medicine Service and an attending physician at Memorial Sloan Kettering Cancer Center and as a professor in the Department of Medicine at Weill Cornell Medical College. He is a past president of ASCO. His research interests include all areas of care related to breast cancer, with a focus on the development of novel systemic therapies and prevention interventions related to obesity and inflammation. Follow Dr. Hudis on Twitter @CliffordHudis.

Disclosure.

Jun 03, 2013
The American Society of Clinical Oncology will mark its 50th year as an organization in 2014, during my term as your President. As I have thought about this upcoming year, I have tried to honor this milestone without using it as a sole focus for our organization.

Pages